Aspire Private Capital’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12
| Closed | -$150 | – | 259 |
|
|
2024
Q3 | $150 | Hold |
12
| – | – | ﹤0.01% | 645 |
|
|
2024
Q2 | $175 | Hold |
12
| – | – | ﹤0.01% | 657 |
|
|
2024
Q1 | $269 | Hold |
12
| – | – | ﹤0.01% | 675 |
|
|
2023
Q4 | $226 | Hold |
12
| – | – | ﹤0.01% | 671 |
|
|
2023
Q3 | $205 | Hold |
12
| – | – | ﹤0.01% | 671 |
|
|
2023
Q2 | $360 | Hold |
12
| – | – | ﹤0.01% | 622 |
|
|
2023
Q1 | $351 | Hold |
12
| – | – | ﹤0.01% | 609 |
|
|
2022
Q4 | $237 | Hold |
12
| – | – | ﹤0.01% | 621 |
|
|
2022
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 619 |
|
|
2022
Q2 | $0 | Buy |
+12
| New | – | ﹤0.01% | 611 |
|